Frankfurt - Delayed Quote EUR
IRADIMED CORPORATION (46K.F)
51.00
+5.60
+(12.33%)
At close: May 30 at 8:01:50 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
75,154.64
73,242.12
65,562.30
53,303.15
41,814.58
Cost of Revenue
17,349.68
16,892.24
15,404.03
12,020.74
9,764.66
Gross Profit
57,804.96
56,349.88
50,158.27
41,282.40
32,049.93
Operating Expense
35,157.13
34,385.15
30,122.81
25,654.76
22,232.24
Operating Income
22,647.84
21,964.73
20,035.46
15,627.65
9,817.68
Net Non Operating Interest Income Expense
--
2,193.15
1,864.11
581.85
34.81
Other Income Expense
136.41
117.59
-161.32
-28.75
-16.20
Pretax Income
24,977.39
24,275.46
21,738.26
16,180.75
9,836.29
Tax Provision
5,192.47
5,041.43
4,545.48
3,352.26
510.82
Net Income Common Stockholders
19,784.92
19,234.03
17,192.78
12,828.49
9,325.47
Diluted NI Available to Com Stockholders
19,784.92
19,234.03
17,192.78
12,828.49
9,325.47
Basic EPS
1.56
1.52
1.36
1.02
0.76
Diluted EPS
1.55
1.50
1.35
1.02
0.74
Basic Average Shares
12,683.14
12,670.22
12,602.95
12,562.86
12,346.17
Diluted Average Shares
12,802.48
12,783.56
12,722.53
12,635.97
12,590.85
Total Operating Income as Reported
22,647.84
21,964.73
20,035.46
15,627.65
9,817.68
Total Expenses
52,506.80
51,277.39
45,526.84
37,675.50
31,996.90
Net Income from Continuing & Discontinued Operation
19,784.92
19,234.03
17,192.78
12,828.49
9,325.47
Normalized Income
19,821.96
19,271.06
17,320.38
12,851.28
9,340.83
Interest Income
--
2,193.15
1,864.11
581.85
34.81
Net Interest Income
--
2,193.15
1,864.11
581.85
34.81
EBIT
22,647.84
21,964.73
20,035.46
15,627.65
9,817.68
EBITDA
23,433.53
22,782.38
20,800.64
16,298.32
11,224.51
Reconciled Cost of Revenue
17,349.68
16,892.24
15,404.03
12,020.74
9,764.66
Reconciled Depreciation
785.69
817.66
765.18
670.67
1,406.82
Net Income from Continuing Operation Net Minority Interest
19,784.92
19,234.03
17,192.78
12,828.49
9,325.47
Total Unusual Items Excluding Goodwill
-46.76
-46.76
-161.32
-28.75
-16.20
Total Unusual Items
-46.76
-46.76
-161.32
-28.75
-16.20
Normalized EBITDA
23,480.28
22,829.14
20,961.95
16,327.07
11,240.71
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9.72
-9.73
-33.71
-5.95
-0.84
12/31/2021 - 8/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade